John G. Clohessy

6.6k total citations · 1 hit paper
50 papers, 3.7k citations indexed

About

John G. Clohessy is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, John G. Clohessy has authored 50 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in John G. Clohessy's work include RNA Research and Splicing (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and RNA modifications and cancer (7 papers). John G. Clohessy is often cited by papers focused on RNA Research and Splicing (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and RNA modifications and cancer (7 papers). John G. Clohessy collaborates with scholars based in United States, Italy and Singapore. John G. Clohessy's co-authors include Pier Paolo Pandolfi, Caterina Nardella, Andrea Alimonti, Emanuele Monteleone, Akinobu Matsumoto, Arkaitz Carracedo, Alessandra Pasut, Jianguo Zhuang, Hugh J.M. Brady and Lloyd C. Trotman and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

John G. Clohessy

50 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide

2016 489 citations Akinobu Matsumoto, Alessandra Pasut et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John G. Clohessy United States	28	2.9k	1.4k	756	411	371	50	3.7k
Laura Lintault United States	7	2.3k 0.8×	1.4k 1.0×	877 1.2×	347 0.8×	163 0.4×	8	3.1k
Patrizia Borsotti Italy	26	1.7k 0.6×	1.0k 0.7×	868 1.1×	291 0.7×	266 0.7×	33	2.9k
Caterina Nardella United States	19	3.1k 1.1×	864 0.6×	1.2k 1.6×	365 0.9×	896 2.4×	26	4.2k
Narendra Wajapeyee United States	31	2.7k 0.9×	941 0.7×	895 1.2×	553 1.3×	247 0.7×	95	3.7k
Daniela Taverna Italy	39	3.2k 1.1×	1.9k 1.3×	1.1k 1.5×	528 1.3×	216 0.6×	92	4.6k
Hariharan Easwaran United States	27	3.1k 1.1×	844 0.6×	833 1.1×	338 0.8×	315 0.8×	48	3.9k
Brian C. Lewis United States	33	3.2k 1.1×	1.3k 0.9×	1.2k 1.6×	297 0.7×	668 1.8×	53	4.4k
Sergei Kozlov Australia	26	3.7k 1.3×	1.2k 0.8×	1.8k 2.3×	270 0.7×	229 0.6×	42	4.3k
Agustin Chicas United States	19	3.4k 1.2×	911 0.6×	1.1k 1.5×	605 1.5×	236 0.6×	20	4.6k
Koei Chin United States	27	2.2k 0.8×	1.0k 0.7×	876 1.2×	244 0.6×	249 0.7×	65	3.4k

Countries citing papers authored by John G. Clohessy

Since Specialization

Citations

This map shows the geographic impact of John G. Clohessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Clohessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Clohessy more than expected).

Fields of papers citing papers by John G. Clohessy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Clohessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Clohessy. The network helps show where John G. Clohessy may publish in the future.

Co-authorship network of co-authors of John G. Clohessy

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Clohessy. A scholar is included among the top collaborators of John G. Clohessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Clohessy. John G. Clohessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Timothy D., Haley E. Manchester, Nicole S. Persky, et al.. (2024). Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer. Cancer Research. 84(19). 3250–3266. 12 indexed citations

Baker, Gabrielle M., Valerie Fein‐Zachary, Adam M. Tobias, et al.. (2023). Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals. Modern Pathology. 36(6). 100121–100121. 2 indexed citations

Lee, Jonathan D., João A. Paulo, Vera Mugoni, et al.. (2021). Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia. Nature Methods. 18(3). 293–302. 7 indexed citations

Zhang, Yang, Tuan M. Nguyen, Xiao‐Ou Zhang, et al.. (2021). Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs. Genome biology. 22(1). 41–41. 113 indexed citations

Gandhi, T. K. B., Ellen P.S. Man, John G. Clohessy, et al.. (2020). Targeting microtubule sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors. Theranostics. 10(6). 2727–2743. 7 indexed citations

Bezzi, Marco, Nina Seitzer, T. Ishikawa, et al.. (2018). Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms. Nature Medicine. 24(2). 165–175. 134 indexed citations

Prete, Alessandro, Agnes S. Lo, Peter M. Sadow, et al.. (2018). Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis. Clinical Cancer Research. 24(23). 6078–6097. 46 indexed citations

Chen, Ming, Lixin Wan, Jiangwen Zhang, et al.. (2018). Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism. Nature Communications. 9(1). 159–159. 37 indexed citations

Clohessy, John G. & Pier Paolo Pandolfi. (2018). The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care. Frontiers in Oncology. 8. 340–340. 17 indexed citations

10.

Ven, Anne L. van de, Paige Baldwin, Ju Qiao, et al.. (2017). Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53- Deficient Prostate Cancer to Radiation. Molecular Cancer Therapeutics. 16(7). 1279–1289. 46 indexed citations

11.

Pasut, Alessandra, Akinobu Matsumoto, John G. Clohessy, & Pier Paolo Pandolfi. (2016). The pleiotropic role of non-coding genes in development and cancer. Current Opinion in Cell Biology. 43. 104–113. 21 indexed citations

12.

Chew, Chen Li, Andrea Lunardi, Federico Gulluni, et al.. (2015). In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K–AKT Signaling at Endosomes. Cancer Discovery. 5(7). 740–751. 72 indexed citations

13.

Patnaik, Akash, Kenneth D. Swanson, Katja Helenius, et al.. (2015). Abstract 5497: Cabozantinib eradicates de novo castrate-resistant PTEN/p53 deficient murine prostate cancer via activation of neutrophil-mediated anti-tumor innate immunity. Cancer Research. 75(15_Supplement). 5497–5497. 1 indexed citations

14.

González‐Billalabeitia, Enrique, Nina Seitzer, Su Jung Song, et al.. (2014). Vulnerabilities of PTEN – TP53 -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition. Cancer Discovery. 4(8). 896–904. 80 indexed citations

15.

Fagoonee, Sharmila, Claudia Bearzi, Ferdinando Di Cunto, et al.. (2013). The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells. PLoS ONE. 8(8). e72300–e72300. 36 indexed citations

16.

Reschke, Markus, John G. Clohessy, Nina Seitzer, et al.. (2013). Characterization and Analysis of the Composition and Dynamics of the Mammalian Riboproteome. Cell Reports. 4(6). 1276–1287. 42 indexed citations

17.

Clohessy, John G., Markus Reschke, & Pier Paolo Pandolfi. (2012). Found in translation of mTOR signaling. Cell Research. 22(9). 1315–1318. 12 indexed citations

18.

Nardella, Caterina, Andrea Lunardi, Giuseppe Fedele, et al.. (2011). Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis. Cancer Research. 71(10). 3669–3675. 17 indexed citations

19.

Alimonti, Andrea, Caterina Nardella, Zhenbang Chen, et al.. (2010). A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. Journal of Clinical Investigation. 120(3). 681–693. 279 indexed citations

20.

Sportoletti, Paolo, Silvia Grisendi, Ke Cheng, et al.. (2008). Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse. Blood. 111(7). 3859–3862. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact